Kiora Pharmaceuticals Inc expected to post a loss of 20  cents a share - Earnings Preview

Kiora Pharmaceuticals

08/08/2022 15:13

* Kiora Pharmaceuticals Inc  KPRX.OQ   KPRX.O  is expected
to show
no change in quarterly revenue when it reports  results on
August 10 (estimated). 
    * ​Refinitiv's mean analyst estimate for Kiora
Pharmaceuticals Inc
is for a loss of 20 cents per share. For the same quarter last
year, the company reported a loss of 35 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 2.2%
in the last three months. ​
    * Wall Street's median 12-month price target for Kiora
Pharmaceuticals Inc is $6​, above​ its last closing price
of $0.15. ​​​

This summary was machine generated August 8 at 14:13 GMT.  All
figures in US dollars  unless otherwise stated